Eastman Chemical Company
Q2 2026 Earnings
Market Reaction
S&P 500 over the same 30 days: +1.97%.
Did EMN Beat Earnings? Q2 2026 Results
Eastman Chemical posted a convincing second-quarter 2026 beat, with adjusted EPS of $1.97 clearing the $1.82 Wall Street consensus by 8.18% and revenue of $2.51 billion running 4.73% ahead of expectations on 9.9% year-over-year growth. The headline driver was a dramatic turnaround in the Chemical Intermediates segment, where revenue surged 39% year-over-year to $643 million, propelled by supply disruptions tied to the ongoing Middle East conflict that lifted selling prices 14% and volumes 24%; the segment swung from an EBIT loss of $30 million to positive EBIT of $58 million. Sequentially, adjusted EBIT margins improved by 350 basis points across the business, reflecting disciplined price-cost management and 8% higher volume mix. For <a href="https://247wallst.com/investing/2026/06/25/1-core-catalyst-makes-eastman-chemicals-4-5-payout-a-premier-safe-haven-for-retirees-mapping-out-the-future/">income-focused investors</a>, the company returned $96 million in dividends during the quarter. Looking ahead, management projected Q3 adjusted EPS to approach Q2's $1.97 level and now expects full-year operating cash flow to approach $900 million, modestly trimmed from prior guidance due to inflationary pressure on accounts receivable.
- 5% higher sales volume/mix and 4% higher selling prices drove 10% YoY revenue growth
- 350-basis-point sequential adjusted EBIT margin improvement
- Chemical Intermediates benefited from supply disruptions and tightening market conditions due to Middle East conflict
- Disciplined price-cost management in specialty businesses offset higher raw material and distribution costs
- Cost reduction initiatives on track to deliver $125-$150 million net of inflation
“The Eastman team delivered a strong second quarter despite continued dynamic macroeconomic conditions. Sales revenue increased 15 percent sequentially driven by strong volume growth across the company and disciplined price-cost management in our specialty businesses. We also delivered strong spread expansion and volume/mix improvement in Chemical Intermediates. These actions resulted in a 350-basis-point sequential increase in our EBIT margin. We also continued to successfully manage the impact of the conflict in the Middle East and secured supply of key raw materials to help customers navigate the uncertainty. Additionally, we built momentum with the commercial ramp up of the Kingsport methanolysis facility and are making progress on a capital-efficient set of options to serve the packaging market.”
Eastman Chemical CEO, on the earnings call
Forward Guidance & Outlook
Eastman remains confident it can significantly improve earnings in 2026 versus 2025. The company expects innovation to be the primary driver of specialty growth for the year, with the Kingsport methanolysis facility building strategic momentum. Cost reduction initiatives of $125 million to $150 million net of inflation remain on track. Capital expenditures are expected to be approximately $400 million. Operating cash flow is now expected to approach $900 million, modestly below prior expectations due to inflationary pressure on accounts receivable. For Q3 2026, management projects adjusted EPS to approach Q2 2026's $1.97. By segment in Q3: Advanced Materials EBIT expected higher from improved price-cost and asset utilization; Fibers earnings expected higher as acetate tow volume increases; Additives & Functional Products expected to decline modestly due to seasonally lower agriculture volume; Chemical Intermediates expected to modestly decline as supply chain disruption impact lessens.
EMN YoY Financials
EMN Revenue by Segment
EMN Revenue by Geography
Figures from SEC filings and company reports. Not investment advice.